DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

 

 

Business Affairs Homepage

Bruker in deal to acquire JPK Instruments JPK makes microscopy instruments for biomolecular and cellular imaging

Medmo lets patients set price for radiology imaging tests A travel industry concept comes to healthcare

First radiology center opens in Zimbabwe capital to help curb shortage Currently 115 radiologists in country of 14 million people

Veritas closes $1 billion GE Healthcare software unit buy Will run newly acquired business as a stand-alone company

Onkos Surgical and Insight Medical partner to bring augmented reality to tumor surgery Could this become the new standard of care?

Praxair in deal to sell European assets to Taiyo Nippon Sanso Move is dependent on the successful closing of the Praxair-Linde merger

Precision X-Ray and Faxitron Bioptics combine business assets Forming a new global leader in biological irradiation

Ultrasound Versus IR: Making decisions about real-time location systems Doing your homework is key to making the right investment in RTLS

DaVita hit with $383.5 million jury verdict in dialysis death suit Three patients suffered cardiac arrest after getting GranuFlo therapy

Alliance completes deal for Piramal Imaging Expanding market presence in molecular imaging

Insurance and pharmacy companies
getting all buddy buddy

Cigna to purchase Express Scripts for $52 billion

by Lauren Dubinsky , Senior Reporter
Following in the footsteps of other insurance giants, Cigna announced on Thursday plans to acquire Express Scripts, the largest pharmacy benefit manager in the U.S., for $52 billion.

The deal, which is expected to close at the end of December, is still awaiting regulatory approval as well as approval from both companies’ shareholders.

Story Continues Below Advertisement

Breast Health Solutions

Innovative AI software solutions built on deep learning for breast tomosynthesis, breast density and 2D mammography. Learn more>



CVS Health, the largest pharmacy health care provider in the country, acquired Aetna in December 2017 for $69 billion. UnitedHealth owns OptumRx and Anthem announced plans in October 2017 to partner with CVS Health to start its own pharmacy business.

David A. Balto, an antitrust lawyer who worked at the Federal Trade Commission and the Justice Department, told the New York Times that federal and state officials may be reluctant to approve the Cigna-Express Scripts deal because that would leave no large independent pharmacy manager for smaller insurers.

Former Attorney General of Louisiana Charles C. Foti Jr., Esq. and the law firm of Kahn Swick & Foti LLC, have announced they are investigating the deal because shareholders of Express will receive only $48.75 in cash and 0.2434 shares of the combined company's stock for each share of Express that they own. The law firm is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the company.

A little over a year ago, a federal judge denied Anthem’s proposed $52 billion merger with Cigna. In January 2017, the federal court also blocked a $37 billion-merger between Aetna and Humana.

“Employers are growing increasingly frustrated with the cost of prescription drugs and a lack of transparency into the economics of how this works,” Jim Winkler, senior vice president for health at benefits manager and broker Aon, part of Aon Plc, told Reuters.

Cigna and Express Scripts claim that the acquisition will lower costs for corporate clients since it will foster more coordination between medical care and pharmacy benefits. It will also provide consumers with greater choice because the companies will work together to create an expanded portfolio of health services.

The transaction is valued at $67 billion — Cigna will owe Express Scripts $15 billion in debt. If the deal closes, Cigna shareholders will own approximately 64 percent of the combined company and Express Scripts shareholders will own approximately 36 percent.

The combined company will have Cigna branding, and its headquarters will be in Bloomfield, Connecticut, which is Cigna’s current headquarters. Thirteen directors will be added to the combined company’s board, including four independent members of the Express Scripts board.

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2018 DOTmed.com, Inc.
ALL RIGHTS RESERVED